Johnson & Johnson (NYSE:JNJ) is one of the 10 best stocks to invest in during a recession. On February 26, 2026, Johnson & ...
A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.
The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...
Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily ...
The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...
Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types ...
The study analyzed data from more than 1.8 million people for 16 years ...
Prostate cancer is the most common cancer in American men, with an estimated 333,830 new cases and 36,320 deaths projected for 2026 for the disease, according to the American Cancer ...
The University of Hawaii confirmed that a ransomware gang stole the data of nearly 1.2 million individuals in August 2025 ...
The data presented by the ministry of health and family welfare revealed that the incidence of cancer cases had continuously been rising in the state; Haryana reported 18,387 cancer deaths, while ...
Hawaii cancer center data breach exposed records of 1.2 million individuals in a 2025 ransomware attack on the University of Hawaii Cancer Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results